The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...
Innovation cycles are shifting at a remarkable pace. Artificial intelligence, biotechnology and clean energy systems now influence how nations design public pol ...
Origin Agritech Limited is a company that’s been working on making better seeds for a while now. They’re really focused on using science, especially with GMOs and gene editing, to help farmers grow ...
Regeneron teams up with Tessera to advance TSRA-196, aiming to correct the genetic cause of AATD as preclinical data support its move toward trials.
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a potential one-and-done treatment for alpha-1 antitrypsin deficiency.
Georgia students broke into the world spotlight after showcasing early Lyme detection advances that could save patients years of suffering.
The field of in vitro modeling of organogenesis and disease has witnessed remarkable progress due to innovations in stem cell ...
Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced that the first patient has been dosed in the company's ...
CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results